T1	Participants 45 84	children with autism spectrum disorders
T2	Participants 210 264	children with autism spectrum disorders ages 3-8 years
T3	Participants 274 302	Phase 1 involved 65 children
T4	Participants 344 472	Participants who had high urinary excretion of toxic metals were selected to continue on to phase 2. In phase 2, 49 participants
